AAAAAA

   
Results: 1-11 |
Results: 11
Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol
Authors: Spahn-Langguth, H Langguth, P
Citation: H. Spahn-langguth et P. Langguth, Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol, EUR J PH SC, 12(4), 2001, pp. 361-367
Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats
Authors: Hanafy, A Langguth, P Spahn-Langguth, H
Citation: A. Hanafy et al., Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats, EUR J PH SC, 12(4), 2001, pp. 405-415
Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy
Authors: Shephard, SE Langguth, P Panizzon, RG
Citation: Se. Shephard et al., Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy, PHOTODERM P, 17(1), 2001, pp. 11-21
Intestinal drug efflux: formulation and food effects
Authors: Wagner, D Spahn-Langguth, H Hanafy, A Koggel, A Langguth, P
Citation: D. Wagner et al., Intestinal drug efflux: formulation and food effects, ADV DRUG DE, 50, 2001, pp. S13-S31
Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity
Authors: Tannergren, C Langguth, P Hoffmann, KJ
Citation: C. Tannergren et al., Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity, PHARMAZIE, 56(4), 2001, pp. 337-342
Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites
Authors: Neuhoff, S Langguth, P Dressler, C Andersson, TB Regardh, CG Spahn-Langguth, H
Citation: S. Neuhoff et al., Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites, INT J CL PH, 38(4), 2000, pp. 168-179
Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors - affinities to intestinal P-glycoprotein
Authors: Hilgeroth, A Dressler, C Neuhoff, S Spahn-Langguth, H Langguth, P
Citation: A. Hilgeroth et al., Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors - affinities to intestinal P-glycoprotein, PHARMAZIE, 55(10), 2000, pp. 784-785
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport
Authors: Hilgendorf, C Spahn-Langguth, H Regardh, CG Lipka, E Amidon, GL Langguth, P
Citation: C. Hilgendorf et al., Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport, J PHARM SCI, 89(1), 2000, pp. 63-75
Characterization of binding properties to human P-glycoprotein: Development of a [H-3]verapamil radioligand-binding assay
Authors: Doppenschmitt, S Langguth, P Regardh, CG Andersson, TB Hilgendorf, C Spahn-Langguth, H
Citation: S. Doppenschmitt et al., Characterization of binding properties to human P-glycoprotein: Development of a [H-3]verapamil radioligand-binding assay, J PHARM EXP, 288(1), 1999, pp. 348-357
Role of P-glycoprotein-mediated secretion in absorptive drug permeability:An approach using passive membrane permeability and affinity to P-glycoprotein
Authors: Doppenschmitt, S Spahn-Langguth, H Regardh, CG Langguth, P
Citation: S. Doppenschmitt et al., Role of P-glycoprotein-mediated secretion in absorptive drug permeability:An approach using passive membrane permeability and affinity to P-glycoprotein, J PHARM SCI, 88(10), 1999, pp. 1067-1072
First-pass metabolism of peptide drugs in rat perfused liver
Authors: Taki, Y Sakane, T Nadai, T Sezaki, H Amidon, GL Langguth, P Yamashita, S
Citation: Y. Taki et al., First-pass metabolism of peptide drugs in rat perfused liver, J PHARM PHA, 50(9), 1998, pp. 1013-1018
Risultati: 1-11 |